Overview
Study information
| Network: | HVTN |
| Grant Affiliation: | NA |
| Strategy: | NA |
| Study Type: | Phase II |
| Species: | Human |
| Stage: | Primary analysis complete |
| Study Start Date: | NA |
| Study Made Public: | NA |
Title
A multisite Phase II clinical trial to evaluate the immunogenicity and safety of ALVAC-HIV vCP1452 alone and combined with MN rgp120
Description
HIVNET 026 (HVTN 026) is a Phase II clinical trial to evaluate the safety and immunogenicity of ALVAC-HIV vCP1452 alone and combined with MN rgp120.
Sign in to see full information about this study and to download study data.
Products
Product info coming soon!Integrated data
No integrated data is available for this study.
Non-integrated data
No non-integrated data is available for this study.